Trial intelligence / Profile preview

Perioperative ketamine for prevention of postoperative cognitive decline

NL-OMON20273Recruiting

Sponsor
Leiden University Medical Center
Start
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in post-operative cognitive decline (POCD) comparing Ketanest with Placebo (2 arms). Primary endpoint: Postoperative cognitive function. Started Sep 2014; status: recruiting.

02

Drugs

esketamine
03

Conditions

post-operative cognitive decline (POCD)

Beyond the preview

Go deeper on NL-OMON20273.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20273.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call